Morgan Stanley Invest Advisors has filed plans with the SEC for a biotechnology fund. The proposed Morgan Stanley Biotechnology Fund will sport A, B, C and D class shares and be managed by the manager's Sector Funds Equity team, including Peter Dannenbaum and Alexander Denner. 

See the list of all the 2002 Most Influential People



Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE